A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess Efficacy and Safety of Neu2000KWL in Patients With Acute Ischemic Stroke Receiving Endovascular Therapy

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 16 Dec 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

11 Dec 2024 According to a GNT Pharma media release, results from this study were presented by Professor Jin Soo Lee at Ajou University Medical Center at the recent International Conference Stroke Update 2024 (ICSU 2024).
11 Dec 2024 Results presented in the GNT Pharma media release.
06 Sep 2022 Results (n=209) assessing the safety and efficacy of nelonemdaz in patients with acute ischemic stroke receiving endovascular reperfusion therapy, published in the Stroke.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com